Nuclear Medicine — MCQs

Nuclear Medicine Indian Medical PG Practice Questions and MCQs

Question 131: What is the half-life of Iodine-131?

A. 13 days
B. 8 days (Correct Answer)
C. 2 days
D. 12 hours

Explanation: **Explanation:** **Iodine-131 (I-131)** is a radioisotope widely used in nuclear medicine for both diagnostic and therapeutic purposes. The correct answer is **8 days** (specifically 8.02 days). This physical half-life is long enough to allow for effective therapeutic destruction of thyroid tissue while being short enough to minimize long-term radiation exposure to the patient. **Breakdown of Options:** * **Option B (8 days):** This is the standard physical half-life of I-131. It decays by emitting both **beta particles** (responsible for the therapeutic effect in treating hyperthyroidism and thyroid cancer) and **gamma rays** (used for imaging). * **Option A (13 days):** This is an incorrect value. However, students often confuse it with **I-123**, which has a half-life of **13 hours**. * **Option C (2 days):** This does not correspond to any common clinical iodine isotope. * **Option D (12 hours):** This is close to the half-life of **I-123 (13.2 hours)**, which is the preferred isotope for diagnostic thyroid scans due to its pure gamma emission and lower radiation dose. **High-Yield Clinical Pearls for NEET-PG:** * **Mode of Decay:** I-131 undergoes **Beta-minus decay**. The beta particles have a tissue penetration range of approximately 1–2 mm, making it ideal for localized thyroid ablation. * **Therapeutic Uses:** Treatment of Graves' disease, toxic multinodular goiter, and well-differentiated thyroid carcinoma (post-thyroidectomy). * **Diagnostic Use:** I-131 is used for "Whole Body Scans" (WBS) to detect metastatic thyroid cancer. * **Contraindication:** Absolute contraindication in **pregnancy** and breastfeeding (crosses the placenta and is secreted in breast milk). * **Comparison:** Remember **Technetium-99m**, the most common isotope in nuclear medicine, has a half-life of **6 hours**.

Question 132: All are true about 18 FDG PET scanning except?

A. Half-life of 18F is 110 minutes. (Correct Answer)
B. Brown adipose tissue shows normal symmetrical uptake.
C. Detects pairs of gamma rays produced.
D. Provides good functional detail but poorer anatomical detail than CT.

Explanation: **Explanation** This question requires an understanding of the physical properties and clinical applications of **18F-Fluorodeoxyglucose (FDG) PET imaging**, a mainstay in oncological imaging. **1. Why Option A is the "Except" (Correct Answer):** The half-life of **Fluorine-18 (18F)** is approximately **110 minutes** (precisely 109.8 minutes). Since the question asks for the statement that is *not* true, and Option A is a factually correct statement, it serves as the correct choice in a "multiple true, one false" format. (Note: In some exam patterns, if all options are technically true, the question may be flawed; however, 110 minutes is the standard high-yield value for 18F). **2. Analysis of Other Options:** * **Option B (Brown Adipose Tissue):** Brown fat is metabolically active and rich in mitochondria. It typically shows **symmetrical, bilateral uptake** in the supraclavicular, axillary, and paraspinal regions, especially in cold environments. This is a normal physiological variant and can be mistaken for malignancy. * **Option C (Gamma Ray Detection):** PET works on the principle of **positron emission**. When a positron meets an electron, **annihilation** occurs, producing **two 511 keV gamma photons** traveling in opposite directions (180° apart), which are detected by the scanner. * **Option D (Functional vs. Anatomical Detail):** PET is a functional imaging modality (mapping glucose metabolism). While it provides excellent physiological data, its spatial resolution is inferior to CT. This is why **PET-CT fusion** is used to provide precise anatomical localization. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** 18F-FDG is a glucose analog transported into cells by **GLUT-1 transporters** and phosphorylated by **hexokinase**. It undergoes "metabolic trapping" because it cannot be further metabolized. * **Patient Preparation:** Patients must fast for 4–6 hours; blood glucose should ideally be **<150–200 mg/dL** to prevent competition between FDG and endogenous glucose. * **Normal Uptake:** Brain (high glucose demand), Heart, Kidneys/Bladder (excretion), and Liver. * **False Positives:** Infection, inflammation (sarcoidosis, TB), and healing wounds.

Question 133: Which bone scan is used to detect bone metastasis?

A. Tc99 MDP (Correct Answer)
B. Th201
C. Tc99 DMSA
D. Tc99 sulphur colloid

Explanation: **Explanation:** **Tc99m-MDP (Methylene Diphosphonate)** is the gold standard radiopharmaceutical for skeletal scintigraphy (bone scan). It works on the principle of **chemisorption**, where the phosphate groups bind to the hydroxyapatite crystals in the bone matrix. Areas with increased osteoblastic activity (bone formation) and increased blood flow—common in metastatic deposits—show high uptake ("hot spots"). It is highly sensitive for detecting early bone metastases, often identifying lesions 6–18 months before they appear on conventional X-rays. **Analysis of Incorrect Options:** * **Thallium-201 (Tl-201):** A potassium analog primarily used for **myocardial perfusion imaging** (stress tests) and occasionally for tumor viability or parathyroid imaging. * **Tc99m-DMSA:** Used for **renal cortical imaging**. It is the investigation of choice for detecting renal scarring and evaluating differential renal function. * **Tc99m-Sulphur Colloid:** Used for **reticuloendothelial system (RES) imaging**, specifically for liver-spleen scans and bone marrow imaging. It is also used in gastric emptying studies and lymphoscintigraphy. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Uptake:** Chemisorption onto hydroxyapatite crystals. * **Flare Phenomenon:** A temporary increase in tracer uptake seen 1–3 months after successful chemotherapy, which should not be confused with disease progression. * **Superscan:** A bone scan showing intense, symmetrical skeletal uptake with **absent or faint renal activity**, typically seen in diffuse metastatic disease (e.g., prostate cancer) or metabolic bone disease. * **Cold Spots:** Some aggressive or purely lytic lesions (e.g., Multiple Myeloma, Renal Cell Carcinoma) may appear as "cold spots" due to a lack of osteoblastic response.

Question 134: What is the best diagnostic method for ectopic gastric mucosa in a Meckel's diverticulum?

A. Fluoroscopy
B. Occult blood test in stool
C. Ultrasound abdomen
D. Radionuclide scan (Correct Answer)

Explanation: **Explanation:** **1. Why Radionuclide Scan is Correct:** The **Meckel’s Scan** (Technetium-99m pertechnetate scan) is the gold standard for diagnosing a Meckel’s diverticulum containing ectopic gastric mucosa. The underlying principle is that **$^{99m}\text{Tc-pertechnetate}$** is actively taken up and secreted by the **mucous cells of the gastric mucosa**, regardless of its location. Since approximately 50% of symptomatic Meckel’s diverticula contain ectopic gastric tissue (which can cause ulceration and painless rectal bleeding), this scan is highly specific for identifying the diverticulum. **2. Why Other Options are Incorrect:** * **A. Fluoroscopy:** Barium studies (like small bowel follow-through) are generally insensitive for Meckel’s diverticulum as the diverticulum often fails to fill with contrast or is obscured by overlapping bowel loops. * **B. Occult blood test:** While this confirms the presence of gastrointestinal bleeding, it is a non-specific screening tool and cannot localize the source or identify the underlying pathology. * **C. Ultrasound abdomen:** Meckel’s diverticulum is difficult to visualize on routine ultrasound unless complications like intussusception or diverticulitis are present. It lacks the functional specificity of nuclear imaging. **3. Clinical Pearls for NEET-PG:** * **Rule of 2s:** 2% of the population, 2 inches long, 2 feet from the ileocecal valve, 2 types of ectopic tissue (Gastric > Pancreatic), and presents by age 2. * **Enhancing the Scan:** To increase the sensitivity of the Meckel’s scan, pharmacological adjuncts are used: * **Pentagastrin:** Increases uptake of pertechnetate by gastric mucosa. * **H2 Blockers (e.g., Cimetidine):** Inhibits the release of the tracer from the cells into the bowel lumen, keeping it localized. * **Glucagon:** Decreases peristalsis, preventing the tracer from being washed away. * **Most common presentation:** Painless lower GI bleeding (hematochezia) in a child.

Question 135: Which isotope is primarily used for thyroid scanning?

A. Iodine-129 (Correct Answer)
B. Iodine-131
C. Technetium-99m
D. Selenium-75

Explanation: **Explanation:** Thyroid scanning relies on the thyroid gland's unique ability to actively trap and organify iodine via the Sodium-Iodide Symporter (NIS). **Why Iodine-123 (I-123) is the preferred isotope:** While the question lists Iodine-129 (likely a typographical variant in some question banks for **Iodine-123**), in clinical practice, **I-123** is the gold standard for thyroid imaging. It emits pure gamma radiation (159 keV), which is ideal for gamma cameras, and has a short half-life (13 hours), resulting in a significantly lower radiation dose to the patient compared to I-131. It allows for both anatomical imaging and functional uptake studies. **Analysis of Incorrect Options:** * **Iodine-131:** Primarily used for **therapeutic** purposes (ablation of thyroid cancer or treatment of Graves' disease). It emits high-energy beta particles which cause tissue destruction. Its long half-life (8 days) makes it less ideal for routine diagnostic scanning due to high radiation exposure. * **Technetium-99m (pertechnetate):** Frequently used as a cheaper, faster alternative for thyroid scans. It is trapped by the thyroid but **not organified**. While useful for quick morphology, it is not the primary physiological tracer of choice. * **Selenium-75:** Historically used in the form of Selenomethionine for parathyroid or pancreatic imaging, but it has no role in routine thyroid scanning. **High-Yield NEET-PG Pearls:** * **Drug of Choice for Grave’s Disease (Imaging):** I-123 (shows diffuse increased uptake). * **Cold Nodule:** A nodule that does not take up isotope; carries a 15-20% risk of malignancy. * **Struma Ovarii:** Diagnosed using I-131/I-123 whole-body scans. * **Wolff-Chaikoff Effect:** Reduction in thyroid hormone levels caused by ingestion of a large amount of iodine.

Question 136: Myocardial uptake gated acquisition (MUGA) scan is done for what purpose?

A. Testing drug toxicity
B. Assessing ventricular function and anthracycline-induced cardiotoxicity (Correct Answer)
C. Evaluating myocardial perfusion
D. None of the above

Explanation: **Explanation:** **1. Why Option B is correct:** A **MUGA scan** (also known as Radionuclide Angiography or Equilibrium Radionuclide Ventriculography) is the gold standard for the objective and reproducible assessment of the **Left Ventricular Ejection Fraction (LVEF)**. It involves labeling the patient's red blood cells with **Technetium-99m (Tc-99m)**. By synchronizing the image acquisition with the R-wave of the ECG (Gating), it allows for the visualization of the heart in motion. Clinically, its most critical application is monitoring patients on **Anthracyclines** (e.g., Doxorubicin), which are notorious for causing dose-dependent, irreversible dilated cardiomyopathy. A drop in LVEF on a MUGA scan often necessitates a change in the chemotherapy regimen. **2. Why other options are incorrect:** * **Option A:** While "drug toxicity" is partially correct, it is too vague. MUGA specifically monitors *cardiotoxicity*, not general drug toxicity. * **Option C:** Myocardial perfusion is evaluated using **Thallium-201** or **Tc-99m Sestamibi/Tetrofosmin** SPECT scans, not MUGA. Perfusion scans look at blood flow to the muscle, whereas MUGA looks at the pumping function (wall motion) of the chambers. **3. High-Yield Clinical Pearls for NEET-PG:** * **Radiopharmaceutical used:** Tc-99m labeled RBCs (In-vivo or In-vitro labeling). * **Key Parameter:** It is considered more accurate and less operator-dependent than Echocardiography for calculating LVEF. * **Anthracycline Cut-off:** A decrease in LVEF of **>10%** to a value below the lower limit of normal (usually <50%) is a significant indicator of cardiotoxicity. * **Other uses:** Evaluation of wall motion abnormalities and shunts.

Question 137: DNA labeling is done by using which of the following isotopes?

A. Technetium-99m (Tc-99m)
B. Phosphorus-32 (P-32) (Correct Answer)
C. Iodine-131 (I-131)
D. Cobalt-60 (Co-60)

Explanation: **Explanation:** The correct answer is **Phosphorus-32 (P-32)**. This is based on the fundamental biochemical structure of nucleic acids. DNA and RNA consist of a sugar-phosphate backbone; therefore, radioactive phosphorus can be incorporated directly into the phosphate groups during DNA synthesis or via enzymatic labeling (e.g., nick translation). * **Why P-32 is correct:** P-32 is a high-energy **pure beta emitter**. Its chemical identity with natural phosphorus allows it to substitute for stable phosphorus in the DNA molecule without altering its biological properties. It is widely used in molecular biology for Northern/Southern blotting and DNA sequencing. **Analysis of Incorrect Options:** * **Technetium-99m (Tc-99m):** The most common isotope in diagnostic nuclear medicine (gamma emitter). It is used for organ imaging (bone, thyroid, kidney) but does not naturally incorporate into the DNA structure. * **Iodine-131 (I-131):** Primarily used for the diagnosis and treatment of thyroid disorders (Grave’s disease, Thyroid CA). While iodine can label proteins (tyrosine residues), it is not a constituent of DNA. * **Cobalt-60 (Co-60):** A gamma emitter used in external beam radiotherapy (Telecobalt units) and sterilization of medical equipment, not for molecular DNA labeling. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic use of P-32:** Historically used to treat **Polycythemia Vera** and essential thrombocythemia due to its ability to suppress bone marrow. * **Pure Beta Emitters:** Remember the mnemonic **"SPY"** (Strontium-89, Phosphorus-32, Yttrium-90). These are used for therapy, not imaging. * **Tritium (H-3):** Another isotope used for DNA labeling (specifically tritiated thymidine), often used in cell proliferation studies.

Question 138: Which is the most sensitive test for metastatic deposits?

A. Isotope scan (Correct Answer)
B. CT scan
C. Skeletal survey
D. Tomography

Explanation: **Explanation:** The **Isotope scan** (specifically the **Technetium-99m MDP bone scan**) is the most sensitive screening test for detecting skeletal metastatic deposits. **1. Why Isotope Scan is Correct:** The sensitivity of a bone scan lies in its ability to detect **functional/metabolic changes** in the bone. It identifies increased osteoblastic activity and increased vascularity at the site of a lesion long before structural changes occur. A bone scan can detect a lesion when there is only a **3–5% change** in bone metabolism. **2. Why Other Options are Incorrect:** * **Skeletal Survey (X-ray):** This is relatively insensitive. A lesion becomes visible on a plain radiograph only after **30–50% of the bone mineral content** is lost. It is often used for specific conditions like Multiple Myeloma (where bone scans may be "cold"). * **CT Scan:** While excellent for evaluating cortical bone and providing anatomical detail, it is less sensitive than an isotope scan for early marrow involvement and is not practical for whole-body screening. * **Tomography:** Conventional tomography is an outdated technique that provides sectional images but lacks the metabolic sensitivity required for early metastasis detection. **Clinical Pearls for NEET-PG:** * **Most Sensitive Overall:** PET-CT (especially for many solid tumors), but among the given options, Isotope scan is the standard answer. * **"Cold" Scan:** Metastatic lesions from **Multiple Myeloma**, thyroid cancer, or highly aggressive anaplastic tumors may appear "cold" (negative) on a bone scan because they are purely osteolytic. * **Flare Phenomenon:** An apparent increase in uptake on a bone scan shortly after starting chemotherapy, which actually represents healing rather than progression. * **Hot Spots:** Common in prostate, breast, and lung cancers.

Question 139: Which radiopharmaceutical is used to estimate renal GFR?

A. TC99m MAG3
B. TC99m DMSA
C. Tc99m DTPA (Correct Answer)
D. All of the above

Explanation: **Explanation:** The estimation of the **Glomerular Filtration Rate (GFR)** requires a radiopharmaceutical that is handled exclusively by glomerular filtration, with neither tubular secretion nor reabsorption. **1. Why Tc99m DTPA is correct:** **Tc99m DTPA (Diethylene Triamine Penta-acetic Acid)** is the gold standard for dynamic renal imaging to estimate GFR. It is a small chelate that is filtered solely by the glomeruli. Because it is not secreted or reabsorbed by the renal tubules, its clearance rate directly reflects the GFR. **2. Why other options are incorrect:** * **Tc99m MAG3 (Mercaptoacetyltriglycine):** This agent is primarily cleared by **tubular secretion** (approx. 95%). It is the agent of choice for estimating **Effective Renal Plasma Flow (ERPF)** and is preferred over DTPA in patients with impaired renal function or suspected obstruction due to its higher extraction fraction. * **Tc99m DMSA (Dimercaptosuccinic Acid):** This is a **static** renal imaging agent. It binds to the proximal convoluted tubules and remains in the renal cortex for a long duration. It is used to evaluate **renal morphology**, cortical scarring (e.g., in pyelonephritis), and differential renal function, but not GFR. **High-Yield Clinical Pearls for NEET-PG:** * **GFR Estimation:** Tc99m DTPA. * **ERPF Estimation:** Tc99m MAG3 (replaced the older I-131 Hippuran). * **Renal Cortical Imaging/Scarring:** Tc99m DMSA. * **Diuretic Renography (Lasix Scan):** Uses DTPA or MAG3 to differentiate between obstructive and non-obstructive hydronephrosis. * **Captopril Scan:** Used for diagnosing **Renovascular Hypertension** (Renal Artery Stenosis).

Question 140: Which radioisotope study is preferred for the detection of parathyroid adenoma?

A. I-131
B. Sestamibi scan (Correct Answer)
C. Thallium-201 scan
D. Tc 99m-MDP

Explanation: **Explanation:** The **Tc-99m Sestamibi scan** (also known as the MIBI scan) is the gold standard nuclear imaging modality for localizing parathyroid adenomas. **Why Sestamibi is the Correct Choice:** The principle relies on **differential washout**. Sestamibi is a lipophilic cation that accumulates in mitochondria-rich cells. Both the thyroid and the hyperfunctioning parathyroid tissue (adenoma) take up the tracer initially. However, the tracer washes out rapidly from normal thyroid tissue but is **retained much longer** in the oxyphil cells of a parathyroid adenoma. Delayed imaging (usually at 2 hours) allows the adenoma to be visualized as a "hot spot" against a faded thyroid background. **Analysis of Incorrect Options:** * **A. I-131:** This is used for imaging and treating **thyroid** pathologies (like Graves' disease or thyroid cancer) because the thyroid gland actively traps and organifies iodine. It has no role in parathyroid imaging. * **C. Thallium-201 scan:** Historically used in a "Subtraction Scan" (Thallium minus Technetium), it is now obsolete. Thallium is taken up by both thyroid and parathyroid, but it has poorer image quality and higher radiation compared to Sestamibi. * **D. Tc 99m-MDP:** This is a phosphonate used for **Bone Scans**. It detects osteoblastic activity and is used for metastases or fractures, not endocrine adenomas. **High-Yield Clinical Pearls for NEET-PG:** * **SPECT/CT:** Combining Sestamibi with CT provides anatomical localization, which is crucial for ectopic parathyroid adenomas (commonly found in the **mediastinum**). * **Dual-Tracer Imaging:** If Sestamibi is unavailable, **Tc-99m Pertechnetate** (thyroid only) can be subtracted from **Tl-201** (thyroid + parathyroid) to isolate the adenoma. * **Intraoperative MIBI:** Can be used with a gamma probe to guide the surgeon during minimally invasive parathyroidectomy.

Practice by Chapter

Physics of Nuclear Medicine

Practice Questions

Radiopharmaceuticals

Practice Questions

Radiation Detection in Nuclear Medicine

Practice Questions

Thyroid Scintigraphy

Practice Questions

Bone Scintigraphy

Practice Questions

Renal Nuclear Medicine

Practice Questions

Cardiac Nuclear Medicine

Practice Questions

Pulmonary Nuclear Medicine

Practice Questions

Neurological Nuclear Medicine

Practice Questions

PET/CT Principles and Applications

Practice Questions

Radionuclide Therapy

Practice Questions

Radiation Safety in Nuclear Medicine

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free